Developer docs
API playgroundTry for free, no card

Search company profiles

INDRE

Full company profile

uuid004n1ks

Namestring
INDRE
Legal namestring
INDRE, Red Internacional de Investigación en Síndrome de Dravet y Epilepsia Refractaria
Company typeenum
Private
Founded yearstring
-
Descriptiontext

INDRE (Red Internacional de Investigación en Síndrome de Dravet y Epilepsia Refractaria) is a collaborative scientific research network and initiative of ApoyoDravet, a non-profit association declared of public utility in Spain. The network is designed to promote research in rare and complex epilepsies by connecting 11 working groups comprising 50 principal investigators and researchers across 20 active projects. Its member institutions span Spain — including Instituto de Neurociencias CSIC-UMH (Alicante), Universidad Complutense de Madrid, Universidad Nebrija, IIS Biobizkaia, Basque Center for Neuroscience Achucarro, CABIMER CSIC, Hospital Vall d'Hebron (Barcelona), Universidad de A Coruña, Universidad de Barcelona, Hospital Ruber Internacional Madrid, and Centro de Investigación Príncipe Felipe (Valencia) — and one international partner, Universidad Nacional de La Plata in Argentina.

The network provides research groups with working tools, visibility, knowledge transfer, technology transfer, and market transfer support, alongside assistance in obtaining funding for rare-epilepsy research projects. It also integrates patient perspectives from ApoyoDravet into research design, hosts the annual INDRE Congreso scientific congress, and offers downloadable research resources including pharmaceutical company program information as Excel files. The network is coordinated by Dr. Luis Miguel Aras Portilla.

INDRE does not generate commercial revenue and operates as a non-profit scientific network. Its funding flows through ApoyoDravet's donation, sponsorship, membership, and voluntary-contribution model rather than via fees for products or services. GTM motion is community-led: research groups and research centers are recruited directly into the network via a 'Join the INDRE ApoyoDravet network' call-to-action, with marketing reach through ApoyoDravet's website (apoyodravet.eu), social media channels (Facebook, Instagram, Twitter, LinkedIn, YouTube), and the annual congress. The network is not an investor-backed corporate entity and therefore presents no traditional ownership, equity, or fundraising profile.

Short descriptiontext

INDRE is a non-profit, community-led collaborative scientific network coordinated by Dr. Luis Miguel Aras Portilla under parent organization ApoyoDravet, connecting 50 researchers across 11 working groups in 20 rare-epilepsy projects in Spain and Argentina.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare epilepsy research, dravet syndrome research, scientific collaboration network, neuroscience research network, refractory epilepsy studies
NAICS code1 code
  • Professional Organizations81392
SIC code1 code
  • Services-Membership Organizations8600
Product category
Medical Research Network
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Non-profit research network
TypeProfessional Services
Description

INDRE is an initiative of ApoyoDravet, a non-profit organization declared of public utility. The network does not generate commercial revenue. Funding appears to come from donations, sponsorships, memberships, and voluntary contributions rather than product/service sales.

apoyodravet.eu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

INDRE is a collaborative scientific research network that promotes research in rare and complex epilepsies, particularly Dravet Syndrome. It provides member research groups with working tools, research visibility, knowledge transfer, technology transfer, and assistance obtaining funding for projects. The network coordinates 50 researchers across 11 working groups and has supported 20 research projects, connecting institutions in Spain and Argentina.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

INDRE (Red Internacional de Investigación en Síndrome de Dravet y Epilepsia Refractaria) is a collaborative scientific research network operated by ApoyoDravet, a non-profit organization. The network does not offer distinct commercial products or software offerings. Instead, it provides a suite of research support services including scientific consulting, clinical study development support, economic sustainability services, and collaborative programs. The network connects 11 working groups comprising 50 researchers across 20 research centers and has facilitated 20 projects. Key services include idea generation and validation, technology transfer, funding support, patient perspective integration, and startup promotion. Research resources are available as downloadable Excel files containing pharmaceutical company program information. The network is coordinated by Dr. Luis Miguel Aras Portilla.

Product and service4 records
1INDRE Collaborative Research Network Membership
CategoryResearch Collaboration Service
Description

Membership-based access to a collaborative scientific research network for academic researchers and principal investigators studying Dravet syndrome and refractory epilepsy. Provides working tools, research visibility, knowledge transfer, technology transfer, market transfer, and funding assistance. Members join 11 working groups and gain access to scientific consulting and collaborative workspaces coordinated by ApoyoDravet.

2Scientific Consulting and Clinical Study Development Support
CategoryResearch Consulting
Description

Consulting services supporting research groups with idea generation, validation, and clinical study development for rare epilepsy research projects. Provided to member researchers as part of the INDRE network infrastructure.

3Technology and Knowledge Transfer Services
CategoryTechnology Transfer Service
Description

Services supporting technology transfer, market transfer, and startup promotion for research outcomes generated by network members. Includes assistance with economic sustainability and commercialization of research findings in the rare epilepsy field.

4INDRE Congreso (Annual Scientific Congress)
CategoryScientific Event
Description

Annual scientific congress bringing together network researchers to discuss advances in rare and complex epilepsies. The IV Congreso INDRE ApoyoDravet featured inauguration with representatives from ApoyoDravet, Comunidad de Madrid, and Universidad Nebrija.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research center led by Principal Investigator Isabel del Pino, contributing to the INDRE network's research efforts in Dravet syndrome and refractory epilepsy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institution represented by PI Onintza Sagredo, providing scientific expertise and hosting research activities within the INDRE network.

3Universidad Nebrija (Madrid)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institution represented by PI Jon Andoni Duñabeitia, participating in collaborative epilepsy research through the INDRE network.

apoyodravet.eu
4IIS Biobizkaia (Bizkaia)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institute hosting PI Paolo Bonifazi, contributing to the network's interdisciplinary research approach.

apoyodravet.eu
5Basque Center for Neuroscience Achucarro
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research center led by PI Juan Manuel Encinas, focusing on neuroscience research within the rare epilepsy network.

apoyodravet.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International partner institution represented by PI Alan Talevi, providing international reach to the INDRE network in Latin America.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Andalusian Center for Molecular Biology and Regenerative Medicine led by PI Manuel Álvarez Dolado, contributing biomedical research expertise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hospital research center represented by PI Víctor Puntes, providing clinical research perspective and patient access.

9Universidad de A Coruña
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institution hosting PI Juan Casto Rivadulla, contributing neuroscience and epilepsy research capabilities.

apoyodravet.eu
10Universidad de Barcelona
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institution represented by PI Sandra Acosta Verdugo, participating in collaborative epilepsy research network activities.

apoyodravet.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hospital research center represented by PI Antonio Gil-Nagel Rein, providing clinical epilepsy expertise and patient care perspective.

12Fundación Iniciativa para las neurociencias
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Foundation partner collaborating with Hospital Ruber Internacional, contributing neurological research focus to the network.

apoyodravet.eu
13Centro de Investigación Príncipe Felipe
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research center part of Universitat Politècnica de València, contributing to the network's multidisciplinary research approach.

apoyodravet.eu
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Parent non-profit organization that initiated the INDRE network. ApoyoDravet is a non-profit entity declared of public utility, dedicated to supporting Dravet syndrome patients and promoting rare epilepsy research. Provides organizational infrastructure, funding support, and patient perspective integration.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based non-profit dedicated to Dravet syndrome that funds research, supports patients, and convenes researchers, directly comparable to INDRE in disease focus, network-coordination role, and patient-advocate-plus-researcher structure.

TypeOthers
Description

US-based non-profit that funds patient-focused epilepsy research and operates a research grants program; comparable to INDRE in its research-fund facilitation role for a specific patient community, but as a funder rather than an operating research network.

3Dravet Syndrome UK
TypeDirect peer
Description

UK non-profit supporting families affected by Dravet syndrome and funding research, with a similar mix of patient support and research-grant facilitation as INDRE, though operating at a national rather than international level.

4Fundación Farmaindustria
TypeOthers
Description

Spanish pharmaceutical industry association that funds biomedical research and clinical trials in Spain; comparable as a potential funding and collaboration partner for INDRE given its role in connecting research consortia with pharma sponsors.

TypeBroad incumbent
Description

EURORDIS is an umbrella non-profit alliance of rare-disease patient organizations across Europe, including Dravet-related groups. It is comparable as an ecosystem convener and policy advocate for rare diseases, but operates at a much broader scale and pan-European remit than INDRE.

6Instituto de Salud Carlos III (ISCIII)
TypeOthers
Description

Spanish public research and funding body for health and biomedical sciences, including rare diseases; comparable as a major funder and convener of Spanish biomedical research networks such as CIBER and RETICS, in which INDRE-aligned researchers may participate.

7Epilepsy Foundation (US)
TypeBroad incumbent
Description

Major US patient-and-research non-profit covering all epilepsies, with programs for research funding, advocacy, and patient services; comparable to INDRE as a combined patient-support and research-promotion entity, though far larger and broader in scope.

TypeBroad incumbent
Description

ILAE is the largest international professional organization in epilepsy, covering all epilepsies rather than focusing specifically on Dravet; comparable as a convener of epilepsy research and clinical community, but much broader in scope than INDRE.

TypeDirect peer
Description

EpiCARE is a pan-European reference network of highly specialized healthcare providers and research centers focused on rare and complex epilepsies, making it the closest functional peer to INDRE's mission of coordinating rare-epilepsy research across multiple institutions and countries.

10Federación Española de Enfermedades Raras (FEDER)
TypeOthers
Description

Spanish federation representing the rare-disease patient community, including ApoyoDravet itself; comparable as the national umbrella under which INDRE's parent operates, providing advocacy and visibility for rare diseases in Spain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

INDRE

Medical Research Networkindrenetwork.com

INDRE is a non-profit, community-led collaborative scientific network coordinated by Dr. Luis Miguel Aras Portilla under parent organization ApoyoDravet, connecting 50 researchers across 11 working groups in 20 rare-epilepsy projects in Spain and Argentina.

What INDRE does

INDRE (Red Internacional de Investigación en Síndrome de Dravet y Epilepsia Refractaria) is a collaborative scientific research network and initiative of ApoyoDravet, a non-profit association declared of public utility in Spain. The network is designed to promote research in rare and complex epilepsies by connecting 11 working groups comprising 50 principal investigators and researchers across 20 active projects. Its member institutions span Spain — including Instituto de Neurociencias CSIC-UMH (Alicante), Universidad Complutense de Madrid, Universidad Nebrija, IIS Biobizkaia, Basque Center for Neuroscience Achucarro, CABIMER CSIC, Hospital Vall d'Hebron (Barcelona), Universidad de A Coruña, Universidad de Barcelona, Hospital Ruber Internacional Madrid, and Centro de Investigación Príncipe Felipe (Valencia) — and one international partner, Universidad Nacional de La Plata in Argentina.

The network provides research groups with working tools, visibility, knowledge transfer, technology transfer, and market transfer support, alongside assistance in obtaining funding for rare-epilepsy research projects. It also integrates patient perspectives from ApoyoDravet into research design, hosts the annual INDRE Congreso scientific congress, and offers downloadable research resources including pharmaceutical company program information as Excel files. The network is coordinated by Dr. Luis Miguel Aras Portilla.

INDRE does not generate commercial revenue and operates as a non-profit scientific network. Its funding flows through ApoyoDravet's donation, sponsorship, membership, and voluntary-contribution model rather than via fees for products or services. GTM motion is community-led: research groups and research centers are recruited directly into the network via a 'Join the INDRE ApoyoDravet network' call-to-action, with marketing reach through ApoyoDravet's website (apoyodravet.eu), social media channels (Facebook, Instagram, Twitter, LinkedIn, YouTube), and the annual congress. The network is not an investor-backed corporate entity and therefore presents no traditional ownership, equity, or fundraising profile.

INDRE firmographics

Firmographics
Name
INDRE
Legal name
INDRE, Red Internacional de Investigación en Síndrome de Dravet y Epilepsia Refractaria
Website
https://indrenetwork.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
INDRE is a non-profit, community-led collaborative scientific network coordinated by Dr. Luis Miguel Aras Portilla under parent organization ApoyoDravet, connecting 50 researchers across 11 working groups in 20 rare-epilepsy projects in Spain and Argentina.
Ownership category
akta.pro rank

Where INDRE is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

INDRE business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others

Revenue model

  1. Non-profit research network: INDRE is an initiative of ApoyoDravet, a non-profit organization declared of public utility. The network does not generate commercial revenue. Funding appears to come from donations, sponsorships, memberships, and voluntary contributions rather than product/service sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

INDRE product offering

Product offering

Core offering

INDRE is a collaborative scientific research network that promotes research in rare and complex epilepsies, particularly Dravet Syndrome. It provides member research groups with working tools, research visibility, knowledge transfer, technology transfer, and assistance obtaining funding for projects. The network coordinates 50 researchers across 11 working groups and has supported 20 research projects, connecting institutions in Spain and Argentina.

Product overview

INDRE (Red Internacional de Investigación en Síndrome de Dravet y Epilepsia Refractaria) is a collaborative scientific research network operated by ApoyoDravet, a non-profit organization. The network does not offer distinct commercial products or software offerings. Instead, it provides a suite of research support services including scientific consulting, clinical study development support, economic sustainability services, and collaborative programs. The network connects 11 working groups comprising 50 researchers across 20 research centers and has facilitated 20 projects. Key services include idea generation and validation, technology transfer, funding support, patient perspective integration, and startup promotion. Research resources are available as downloadable Excel files containing pharmaceutical company program information. The network is coordinated by Dr. Luis Miguel Aras Portilla.

Differentiator

Problem solved

Functional benefit

Products and services

  • INDRE Collaborative Research Network Membership Membership-based access to a collaborative scientific research network for academic researchers and principal investigators studying Dravet syndrome and refractory epilepsy. Provides working tools, research visibility, knowledge transfer, technology transfer, market transfer, and funding assistance. Members join 11 working groups and gain access to scientific consulting and collaborative workspaces coordinated by ApoyoDravet.
  • Scientific Consulting and Clinical Study Development Support Consulting services supporting research groups with idea generation, validation, and clinical study development for rare epilepsy research projects. Provided to member researchers as part of the INDRE network infrastructure.
  • Technology and Knowledge Transfer Services Services supporting technology transfer, market transfer, and startup promotion for research outcomes generated by network members. Includes assistance with economic sustainability and commercialization of research findings in the rare epilepsy field.
  • INDRE Congreso (Annual Scientific Congress) Annual scientific congress bringing together network researchers to discuss advances in rare and complex epilepsies. The IV Congreso INDRE ApoyoDravet featured inauguration with representatives from ApoyoDravet, Comunidad de Madrid, and Universidad Nebrija.

Companies that use INDRE

Customer profile

Segments1 record

Ideal customer profiles1 record

INDRE technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

INDRE partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and flagship.

  • Instituto de Neurociencias CSIC-UMH (Alicante)coreStrategic or Co-development PartnerResearch center led by Principal Investigator Isabel del Pino, contributing to the INDRE network's research efforts in Dravet syndrome and refractory epilepsy.
  • Universidad Complutense de MadridcoreStrategic or Co-development PartnerResearch institution represented by PI Onintza Sagredo, providing scientific expertise and hosting research activities within the INDRE network.
  • Universidad Nebrija (Madrid)coreStrategic or Co-development PartnerResearch institution represented by PI Jon Andoni Duñabeitia, participating in collaborative epilepsy research through the INDRE network.
  • IIS Biobizkaia (Bizkaia)coreStrategic or Co-development PartnerResearch institute hosting PI Paolo Bonifazi, contributing to the network's interdisciplinary research approach.
  • Basque Center for Neuroscience AchucarrocoreStrategic or Co-development PartnerResearch center led by PI Juan Manuel Encinas, focusing on neuroscience research within the rare epilepsy network.
  • Universidad Nacional de La Plata (Argentina)coreStrategic or Co-development PartnerInternational partner institution represented by PI Alan Talevi, providing international reach to the INDRE network in Latin America.
  • CABIMER, CSICcoreStrategic or Co-development PartnerAndalusian Center for Molecular Biology and Regenerative Medicine led by PI Manuel Álvarez Dolado, contributing biomedical research expertise.
  • Hospital Vall d'Hebrón (Barcelona)coreStrategic or Co-development PartnerHospital research center represented by PI Víctor Puntes, providing clinical research perspective and patient access.
  • Universidad de A CoruñacoreStrategic or Co-development PartnerResearch institution hosting PI Juan Casto Rivadulla, contributing neuroscience and epilepsy research capabilities.
  • Universidad de BarcelonacoreStrategic or Co-development PartnerResearch institution represented by PI Sandra Acosta Verdugo, participating in collaborative epilepsy research network activities.
  • Hospital Ruber Internacional MadridcoreStrategic or Co-development PartnerHospital research center represented by PI Antonio Gil-Nagel Rein, providing clinical epilepsy expertise and patient care perspective.
  • Fundación Iniciativa para las neurocienciascoreStrategic or Co-development PartnerFoundation partner collaborating with Hospital Ruber Internacional, contributing neurological research focus to the network.
  • Centro de Investigación Príncipe FelipecoreStrategic or Co-development PartnerResearch center part of Universitat Politècnica de València, contributing to the network's multidisciplinary research approach.
  • ApoyoDravetflagshipStrategic or Co-development PartnerParent non-profit organization that initiated the INDRE network. ApoyoDravet is a non-profit entity declared of public utility, dedicated to supporting Dravet syndrome patients and promoting rare epilepsy research. Provides organizational infrastructure, funding support, and patient perspective integration.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

INDRE competitors and assessment

Company assessment

Direct peers

  • Dravet Syndrome Foundation: US-based non-profit dedicated to Dravet syndrome that funds research, supports patients, and convenes researchers, directly comparable to INDRE in disease focus, network-coordination role, and patient-advocate-plus-researcher structure.
  • Dravet Syndrome UK: UK non-profit supporting families affected by Dravet syndrome and funding research, with a similar mix of patient support and research-grant facilitation as INDRE, though operating at a national rather than international level.
  • EpiCARE (European Reference Network for rare and complex epilepsies): EpiCARE is a pan-European reference network of highly specialized healthcare providers and research centers focused on rare and complex epilepsies, making it the closest functional peer to INDRE's mission of coordinating rare-epilepsy research across multiple institutions and countries.

Others

  • CURE Epilepsy: US-based non-profit that funds patient-focused epilepsy research and operates a research grants program; comparable to INDRE in its research-fund facilitation role for a specific patient community, but as a funder rather than an operating research network.
  • Fundación Farmaindustria: Spanish pharmaceutical industry association that funds biomedical research and clinical trials in Spain; comparable as a potential funding and collaboration partner for INDRE given its role in connecting research consortia with pharma sponsors.
  • Instituto de Salud Carlos III (ISCIII): Spanish public research and funding body for health and biomedical sciences, including rare diseases; comparable as a major funder and convener of Spanish biomedical research networks such as CIBER and RETICS, in which INDRE-aligned researchers may participate.
  • Federación Española de Enfermedades Raras (FEDER): Spanish federation representing the rare-disease patient community, including ApoyoDravet itself; comparable as the national umbrella under which INDRE's parent operates, providing advocacy and visibility for rare diseases in Spain.

Broad incumbents

  • EURORDIS (Rare Diseases Europe): EURORDIS is an umbrella non-profit alliance of rare-disease patient organizations across Europe, including Dravet-related groups. It is comparable as an ecosystem convener and policy advocate for rare diseases, but operates at a much broader scale and pan-European remit than INDRE.
  • Epilepsy Foundation (US): Major US patient-and-research non-profit covering all epilepsies, with programs for research funding, advocacy, and patient services; comparable to INDRE as a combined patient-support and research-promotion entity, though far larger and broader in scope.
  • International League Against Epilepsy (ILAE): ILAE is the largest international professional organization in epilepsy, covering all epilepsies rather than focusing specifically on Dravet; comparable as a convener of epilepsy research and clinical community, but much broader in scope than INDRE.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

INDRE social profiles

Digital presence

INDRE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

INDRE leadership team

Management profile

Number of profiles

Profiles1 record

INDRE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

INDRE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INDRE

What does INDRE do?

INDRE is a collaborative scientific research network that promotes research in rare and complex epilepsies, particularly Dravet Syndrome. It provides member research groups with working tools, research visibility, knowledge transfer, technology transfer, and assistance obtaining funding for projects. The network coordinates 50 researchers across 11 working groups and has supported 20 research projects, connecting institutions in Spain and Argentina.

Is INDRE a public or private company?

INDRE is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was INDRE founded?

INDRE was founded in -1. It employs 11 to 50 people.

Where is INDRE based?

INDRE is headquartered in Madrid, Spain, in the Europe region.

How does INDRE make money?

One revenue line is on record: non-profit research network.

Who are INDRE's main competitors?

Direct peers on record are Dravet Syndrome Foundation, Dravet Syndrome UK and EpiCARE (European Reference Network for rare and complex epilepsies). Others are CURE Epilepsy, Fundación Farmaindustria, Instituto de Salud Carlos III (ISCIII) and Federación Española de Enfermedades Raras (FEDER). Broad incumbents are EURORDIS (Rare Diseases Europe), Epilepsy Foundation (US) and International League Against Epilepsy (ILAE).

Does INDRE have an API?

No public API is recorded for INDRE.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales